Feb 20, 2018 08:49AM
Apr 25, 2017 07:00AM
Oct 11, 2016 09:19AM
May 4, 2016 11:13AM
Apr 27, 2016 09:59AM
Jan 15, 2016 03:53PM
Jan 11, 2016 07:50AM Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
Jan 11, 2016 07:32AM
Jan 11, 2016 07:30AM
Dec 3, 2015 09:29AM
Nov 24, 2015 05:26PM
Nov 24, 2015 03:21PM
Nov 2, 2015 06:03AM
Nov 2, 2015 06:00AM Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Aug 4, 2015 07:30AM
May 6, 2015 10:26AM
Mar 27, 2015 01:35PM
Feb 12, 2015 02:49PM
Nov 5, 2014 11:01AM
Nov 4, 2014 10:52AM
Oct 21, 2014 07:11AM Deutsche Bank Resumes Shire (SHPG) at Buy
Oct 15, 2014 03:24PM
Oct 15, 2014 10:15AM
Jul 18, 2014 10:11AM
Jul 18, 2014 06:24AM
Mar 28, 2014 01:26PM
Sep 20, 2013 08:37AM
Sep 13, 2013 02:56PM ViroPharma (VPHM) Fair Value $46-$52 in M&A Scenarios - Deutsche Bank

55,244 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All